Effect of Bael Leaves on Antidiabetic Activity: A clinical study
by Forest Raga February 20, 2021
The present study was carried out to investigate the efficacy and safety of the Bael Leaves on Antidiabetic Activity
For carrying out the study, the clinical protocol was set and approved by the institutional ethical committee. This study was performed under the supervision of physicians. Inclusion and exclusion criteria were formed for the study. Written consent was taken from the patients. Initial postprandial blood glucose level (PPBGL) was estimated at the time of enrolment in the study and then after one month of the study. At the end of the study, the initial and final readings were compared
- Type 2 diabetic patients with fasting plasma glucose levels equal to or greater than 140 mg/dl of blood without any detectable/visible complications .
- Type 2 diabetic patients taking oral hypoglycemic agents with a history of inadequate control of blood glucose with these agents.
- The patients were of either sex (male or female) between the ages of 35-60 years.
There were significant changes in PPBGL of groups IV and I as compared to groups II and III. There were no significant results seen in group II. The results are summarized in Table 1 and Fig. 1
Fig. 1: Comparison of antidiabetic effect on PPBGL in NIDDM patients
BL can be combined in high doses with oral hypoglycemic agents to bring the blood glucose to normal levels in patients whose diabetes is not controlled with these agents or in those patients in whom these drugs produce adverse effects on dose increments. Our study has opened up a new direction for future large-scale clinical research to find an alternative and inexpensive herbal formulation for the NIDDM.
If you want to include Bael Leaves in your daily schedule click here.
Subscribe to learn more.
To read the detailed research experiment, please click here.